Among its four molecular subtypes, TNBC and HER2-positive types are the most aggressive, with high invasiveness, poor prognosis, and significant mortality—TNBC alone accounting for 83% of breast cancer deaths [3]. This evidence concerns the gene ERBB2 and breast carcinoma.